Angulo Cuesta, JavierVirseda Chamorro, MiguelArance Gil, José IgnacioRuiz Graña, SoniaOjea, AntonioCarballo, ManuelRodríguez Alonso, AndrésPereira, JavierTeyrouz, AntoineCruz, FranciscoEt al.2022-03-312022-03-312020Angulo, J., Virseda-Chamorro, M., Arance, I., Ruiz, S., Ojea, A., Carballo, M., Rodríguez, A., Pereira, J., Teyrouz, A., Rebassa, M., Escribano, G., Teba, F., Celada, G., Madurga, B., Martins, F. E., Mendes, P. A., & Cruz, F. (2020). Long-term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study. Neurourology and Urodynamics, 39(6), 1737–1745. https://doi.org/10.1002/nau.244100733-24671520-6777http://hdl.handle.net/11268/10990Aim: The aim of this study is to evaluate long-term durability and effectiveness of the adjustable transobturator male system (ATOMS). Materials and methods: The retrospective multicenter Iberian ATOMS study (n = 215) was updated to evaluate long-term continence status, complications, explants, and secondary treatments. Mean follow-up from surgery to March 2020 was 60.6 ± 18.4 months (range, 39-91). Eleven patients deceased of an unrelated causes. Kaplan-Meier curves were performed to evaluate device durability and incontinence free of recurrence interval. The multivariate analysis defined the population at risk of device explant. Results: A total of 155 patients were dry at the last follow-up visit (72.1%); 99 (46%) used no pads and 56 (26%) used a security pad/day with urine loss less than 10 mL; 96% of dry patients after adjustment remained free of incontinence 1 year later, 93.6% 2 years later, 91.1% 3 years later, 89.2% 5 years later, and 86.7% 8 years later. Complications during follow-up occurred in 43 of 215 (20%). In total, 25 (11.6%) devices were explanted and causes were inefficacy 11 (44%), inefficacy and pain 3 (12%), port erosion 10 (40%), and wound infection 1 (4%). The secondary implant was performed in 11 (5.1%) cases, 6 artificial urinary sphincter and 5 repeated ATOMS. Time to explant was associated to complications (P < .0001), baseline stress urinary incontinence (SUI) severity (P = .01), and former irradiation (P = .03). Multivariate analysis revealed complications (hazard ratio [HR] = 8.71; 3.83-19.82), baseline SUI severity (>5 compared to 1-2 pads/day; HR = 14.9; 1.87-125), and irradiation before ATOMS (HR = 2.26; 1.02-5.18) predicted earlier ATOMS explant. Three cases received radiation after implant without complication. Conclusions: ATOMS device is efficacious and safe in the long term. Determinants for device explant include complications, baseline severity of incontinence, and previous irradiation. Currently, the durability of the device after 5 years is reassuring.engIncontinencia urinariajournal article10.1002/nau.24410restricted accessSistema endocrinoCirugíaTecnología médica